Nanomedicine - a promising therapy for hematological malignancies
- 7 May 2020
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 8 (9), 2376-2393
- https://doi.org/10.1039/d0bm00129e
Abstract
Hematological tumors are a group of diseases defined as the clonal proliferation of blood-forming cells. In recent years, incidences of hematological malignancies have increased. Traditional methods of diagnosing hematological tumors are primarily based on observing morphological features under light microscopy, and molecular diagnostics and immunological indicators are powerful auxiliary diagnostic methods. However, traditional methods cannot efficiently identify tumor markers and limit the efficiency and accuracy of diagnosis. Although treatment methods have been improved continuously, chemotherapy remains a primary technique for the treatment of hematological tumors. Traditional chemotherapy exhibits poor drug selectivity and lacks good biocompatibility and pharmacokinetic properties. The therapeutic effect is not ideal and the risk of toxic side effects is high. The nanosize and surface charge properties of nanodrugs are effective in improving drug delivery efficiency. The high load and rich surface modification methods of nanomaterials provide various possibilities for improving the biocompatibility and pharmacokinetics of drugs, as well as the targeting of drugs. In addition, a nanomedicine loading platform can load multiple drugs simultaneously and design the optimal proportion of combined drug schemes, which can improve the efficacy of drugs and reduce the occurrence of drug resistance. With their unique physical and chemical properties and biological characteristics, the application of nanoparticles in the diagnosis and treatment of hematological tumors has received considerable attention. In this review, we summarize recent advances in the application of various types of nanostructures for the diagnosis and treatment of hematological malignancies, investigate the advantages of nanomedicine compared with the traditional diagnosis and treatment of hematological tumors, and discuss their biological security and application prospects.Funding Information
- National Natural Science Foundation of China (8157010694, 51820105004)
- Ministry of Science and Technology of the People's Republic of China (2018ZX10301402)
- Guangzhou Municipal Science and Technology Project (201707010094, 201704020095)
- Guangdong Province Introduction of Innovative R&D Team (2013S086, 2016ZT06S252, 2016ZT06S029)
- Science and Technology Planning Project of Shenzhen Municipality (JCYJ20170307141438157, JCYJ20170818103626421)
This publication has 102 references indexed in Scilit:
- Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphomaBiomaterials, 2013
- Multivalent DNA Nanospheres for Enhanced Capture of Cancer Cells in Microfluidic DevicesACS Nano, 2013
- Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemiaBlood, 2013
- Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple MyelomaMolecular Therapy, 2012
- Toxicology of Nanomaterials Used in NanomedicineJournal of Toxicology and Environmental Health, Part B, 2011
- Multiplexed Detection and Characterization of Rare Tumor Cells in Hodgkin’s Lymphoma with Multicolor Quantum DotsAnalytical Chemistry, 2010
- Minimal Residual Disease Quantitation in Acute Myeloid LeukemiaClinical Lymphoma Myeloma and Leukemia, 2009
- Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain FvJournal of Controlled Release, 2008
- Selective Probing and Imaging of Cells with Single Walled Carbon Nanotubes as Near-Infrared Fluorescent MoleculesNano Letters, 2008
- Aptamer-Conjugated Nanoparticles for the Collection and Detection of Multiple Cancer CellsAnalytical Chemistry, 2007